An aging population with increasing healthcare demands, the failure of drug candidates in late clinical phase, lack of suitable biomarkers, emerging and persisting infectious diseases in the absence of adequate prevention and treatment, the patent cliff, increasing regulatory hurdles amid an economic crisis - drug development may not be the most comfortable place to be.

How can, how must Pharmaceutical Sciences and Scientists contribute to this emerging European research environment? Which are the research priorities and objectives, how do the related implementation strategies look like? Who are the stakeholders, how are PPPs created and maintained? And how can research be translated to benefit European as well as global healthcare infrastructures? These are some questions we would like to address at this symposium with the implication of the EUFEPS membership and its networks, as well as outside partners.

The EUFEPS Annual Meeting is a three-day event with the opportunity to hold network and executive committee meetings prior to and after the symposium. The format is a mix of keynote lectures and workshops, along with podium discussions with contributions from the networks. Issues to be addressed are both the overarching topic as well as specific themes to be discussed from different perspectives.

The next EUFEPS Annual Meeting will be held from February 19 to 21, 2025 in Vienna, Austria. Please visit the conference webpage for more information: https://annualmeeting.eufeps.org/

EUFEPS Annual Meeting Series

EUFEPS Annual Meeting 2024

May 23 - May 25, 2024

Debrecen, Hungary

Within this event, the Hungarian Pharmaceutical Society celebrated the 100th anniversary. More than 500 participants from 24 countries were attracted to this Meeting 2024, which took place between May 23 and 25 2024.

The aim of this scientific event is to invite the members of the EUFEPS Member societies and also colleagues from other European countries under the umbrella of EUFEPS to building up closer collaboration between pharmacists and other members of the scientific community dealing with drug research and development, and to strengthening the European spirit in Europe.

Prof. Eva Szökö, chairman of the conference, and Prof. Maria Blanco-Prieto, President of EUFEPS, opened the meeting.

Oral lecturers discussed different hot topics in drug research and development. Their presentations were well received and initiated very interesting scientific discussions concerning their specific topics.

In a round table discussion, the EurSci4health platform discussed on the topic "Actualities in the Field of Medical and Drug Devices – Regulatory and Scientific Point of Viewhow scientists can engage and influence agendas on a European level".

In the poster section, many talented young scientists presented their latest research results covering various aspects of drug discovery and drug development.

For the second time, EUFEPS organized a competition between PhD students from different member societies. In total, 9 candidates competed in a special session by giving an overview of their work in 5 min.

MAIN TOPICS

Advanced drug delivery for chronic diseases
Bioorganic and Medicinal Chemistry
Challenges and Solutions in Biosimilar Product Development
Challenges we face: being a hospital pharmacist in the XXI century
Clinical Pharmacy, Digital Health, Pharmacoepidemiology and Precision Medicine
Innovation in Pharma Industry in Larger and Smaller Companies
Natural Products in the Medicine and Recent Progresses in Natural Products and Medicinal Plant Research
Novel carriers for novel drugs
Pharmaceutical and Biomedical Analysis
QbD & PAT in Manufacturing
Radiopharmaceuticals legislation and production
Recent Progresses in Drug Formulation and Development of Dosage Forms
Recent Progresses in Pharmaceutical Technology
Recent Progresses in Pharmacological Research
Regulation of medicines in both disciplines – human and veterinary medicine: Significance, concerns, common grounds
Richter Symposium
Roundtable: Actualities in the Field of Medical and Drug Devices – Regulatory and Scientific Point of View
Symposium of pharmacogenomics (EPRIN) network
Hospital Pharmacists’ Satellite Symposium (3 sections, in Hungarian)
PhD student Competition

EUFEPS Annual Meeting 2023

May 31 - June 2, 2023

Lisbon, Portugal

More than 255 participants from 29 countries were attracted to the EUFEPS Annual Meeting 2023, which took place between May 29 and June 2 2023, at the University of Lisbon, Lisbon, Portugal.

The aim of this scientific event is to invite the members of the EUFEPS Member societies and also colleagues from other European countries under the umbrella of EUFEPS to building up closer collaboration between pharmacists and other members of the scientific community dealing with drug research and development, and to strengthening the European spirit in Europe.

Prof. Joao Lopes, chairman of the conference, and Prof. Maria Blanco-Prieto, President of EUFEPS, opened the meeting and the audience was welcomed by Beatriz da Silva Lima (Dean Lisbon University).

Oral lecturers discussed different hot topics in drug research and development. Their presentations were well received and initiated very interesting scientific discussions concerning their specific topics.

During a very interesting round table discussion, Rogério Gaspar (WHO), Hubert Leufkens (Utrecht University) and Alexandre Guedes Silva (SPEM - President of the Portuguese Association of Multiple Sclerosis) discussed different views on Emerging therapies: regulatory perspective. The discussion was led by Margarida Sousa (Journalist, CNN Portugal).

In another round table discussion, the EurSci4health platform discussed how scientists can engage and influence agendas on a European level.

In the poster section, many talented young scientists presented their latest research results covering various aspects of drug discovery and drug development.

For the first time, EUFEPS organized a competition between PhD students from different member societies. In total, 10 candidates competed in a special session by giving an overview of their work in 5 min. The jury members, Dr. Thomas Sauer (Sanofi Aventis, Germany), Dieter Steinhilber (University Frankfurt, Germany) and Ana Grenha (University of Algarve, Portugal) asked a question to each candidate. Cristina Casadidio (FIGON), Souhaila El Moukhtari (Spain) and Gülşen Aybar Tural (Turkey) have been selected by the jury as the best three candidates.

MAIN TOPICS

◆ Expanding the role of nano drug delivery system in an evolving scenario for global health
◆ EFMC-Innovative approaches for sustainable Drug Discovery
◆ Lipid based drug delivery
◆ Particle design
◆ Pharmacogenomics at the Tipping Point
◆ New drug Formulations for precision medicine
◆ Translating Science: Bench to Bedside
◆ Strategies for the preservation of effective antibiotics – the One Health Concept in application
◆ Regulation of orphan medicinal products: a strong learning device for regulatory science
◆ Drug delivery to Skin: Local and Systemic applications
◆ Tailoring clinical pharmacotherapy to patients’ needs
◆ Sustainable/Green pharmacy
◆ In vitro tools to predict in vivo bioavailability of drugs
◆ Radiopharmacy

EUFEPS Annual Meeting 2022

June 1 - 3, 2022

Leiden, The Netherlands

The EUFEPS Annual meeting 2022 was organised as a cmobined meeting togehter with the Dutch Medicine Days. It focused on the theme “Boosting Sustainable Drug Development in Europe - Top Science Below Sea level”. The aim of the combined conference is to bring together people fro m all over the world who are involved in pharmaceutical sciences in order to exchange the latest results, experiences, and information and to build communication and collaboration at regional and global scales. The main track of the meeting were continued throughout the scientific programme on June 1 to 3 including parallel sessions organized by our FIGON and EUFEPS Networks as well as other leading European science networks/research consortiums. Talks on each session were selected from the submitted abstracts. Young researchers had the opportunities to give short talks which were selected from the submitted abstracts.

MAIN TOPICS

◆ ENSURING TARGET BIOAVAILABILITY AND BIOEQUIVALENCE IN INNOVATIVE DRUG DELIVERY
◆ VETERINARY MEDICINES AND THE WHO ONE HEALTH CONCEPT
◆ SYSTEMS PHARMACOLOGY: CROSSING DISCIPLINARY BORDERS
◆ REAL WORLD DATA, REAL LIFE SCIENCE - CITIZEN SCIENCE
◆ THE FLAGSHIP INITIATIVE ‘ACCELERATING CLINICAL TRIALS IN EUROPE (ACT-EU) – CHALLENGES AND OPPORTUNITIES FROM ETHICAL PERSPECTIVES
◆ INHALATION OF BIOLOGICS AND VACCINES: PHARMACEUTICALS ASPECTS AND EFFICACY
◆ NANOMEDICINES AND NANOSIMILARS: QUALITY, EFFICACY, SAFETY
◆ NEW DEVELOPMENTS IN MEDCHEM
◆ DISEASE INTERCEPTION - ON THE MIDWAY BETWEEN PREVENTION AND TREATMENT
◆ HUMAN ORGANOIDS, AS RELEVANT MODELS FOR CHRONIC DISEASES

EUFEPS Annual Meeting 2021

June 7 - 9, 2021

Virtual Meeting

The EUFEPS Annual meeting 2021 was focused on the theme “Bridging the gap between the patient and the product design”. The meeting was held in collaboration with Chalmers University of Technology, AstraZeneca, Swedish Drug Delivery Forum and Swedish Pharmaceutical Society.The main track of the meeting were continued throughout the scientific programme on June 7 to 9 covering aspects of academic work and industrial application in a multitude of areas within pharmaceutical sciences. We will also make a lessons learnt session about drug treatments of COVID-19. Talks on each session were selected from the submitted abstracts. Young researchers had the opportunities to give short talks which were selected from the submitted abstracts.

MAIN TOPICS

◆ Characterisation: QbD
◆ Drug delivery
◆ Characterisation
◆ Manufacturing
◆ Recent progress oral biopharmaceutics
◆ Systems Pharmacology
◆ Pharmacogenetics Research and Implementation
◆ Frontiers in Drug Discovery
◆ Regulatory science
◆ Veterinary Medicines
◆ Bioavailability and Biopharmaceutics

EUFEPS Annual meeting 2019

March 6 - 8, 2019

Frankfurt, Germany

The EUFEPS Annual meeting 2019 was focused on the theme “Personalized Medicines, Targeted Therapies, Precision Drug Delivery”. The main track of the meeting were continued throughout the scientific programme on March 6 to 8 covering aspects of personalized medicines, recent drug developments, new drug targets and drug delivery. Talks on each session were selected from the submitted abstracts. Young researchers had the opportunities to give short talks which were selected from the submitted abstracts.

MAIN TOPICS

◆ Oncology

◆ NBCDs, Nanomedicines and Nanosimilars

◆ Biomarkers for personalized medicines

◆ Targeted Drug Delivery and Age-appropriate Formulations

◆ Personalized Medicine Outside of Oncology

◆ Analytical Technologies

◆ Veterinary Medicines

◆ Pharmacogenetics Research and Implementation

◆ Process Analytical Contro

EUFEPS Annual Meeting 2018

October 7 - 8, 2008

Gothenburg, Sweden

This meeting focused on the theme “Crossing Barriers for Future Medicines”. The main track of the meeting was continued throughout the scientific programme on May 24 to 26 covering basic sciences in oral and mucosal drug absorption and transport to innovative medicines and their PK/PD evaluation.
As the concept of future medicines involves an extensive systems approach for both development and for preclinical and clinical evaluation, parallel tracks were organized by networks and EUFEPS member institutions and societies to discuss different aspects. Among these tracks available to the Athens 2018 participants, Nanomedicines tracks were organized by EUFEPS Network on Nanomedicine and Hellenic Society on Nanotechnology for Health Sciences HSNanoHS. Biotech and Biosimilars and Manufacturing of Future Medicines tracks were co-organized with industry, Novel Molecular Targets and New Oncology Drugs track were held by German Pharmaceutical Society, Personalized Medicine tracks were organized by EUFEPS Network on Systems Pharmacology and Pharmacogenetics network EPRIN.

MAIN TOPICS

◆ Physiology of the GI tract relevant for drug absorption

◆ Nanomedicines and nanosimilars: How to assess how similar?

◆ Performance of dosage forms in the body and impact on drug absorption

◆ Drug absorption, dissolution and in-silico modelling – towards prediction paradise?

◆ Manufacturing of future medicines

◆ Biotech and Biosimilars

◆ New drugs in Oncology

EUFEPS Annual Meeting 2015

June 15-17, 2015

Geneva, Switzerland

The EUFEPS Annual Meeting 2015 brought together representatives of pharmaceutical sciences in industry, academia and regulatory agencies for discussion and exchange of
ideas in current and future strategies for the development of better medicines. The focus of the meeting was on highlighting issues related to different stages of the development process, such as systems pharmacology, predictive toxicology, novel approaches in pharmaceutical manufacturing (continuous processing, personalised medicines manufacturing), risk assessment and pharmacovigilance. The meeting were completed by an educational workshop on nanomedicine and a thematic session organised by the European Federation of Medicinal Chemistry (EFMC).
The conference was organised by EUFEPS and the School of Pharmaceutical Sciences Geneva-Lausanne (EPGL), and held under the auspices of the European Federation for
Medcinal Chemistry (EFMC), the European Federation of Clinical Nanomedicine (CLINAM), and the Swiss Academy of Pharmaceutical Sciences (SAPhS).

MAIN TOPICS

◆ Educational workshop on Nanomedicine

◆ Medicinal Chemistry

◆ New concepts of drug treatment

◆ Drug development - predictive toxicology, predictive translations

◆ New systems in manufacturing

◆ Medicines usage and its consequences

EUFEPS Annual Meeting 2014

June 16–18, 2014

Uppsala, Sweden

EUFEPS is there to advance sciences for better medicines and health. To this end, EUFEPS also engages with policy makers in Europe (parliament, commission, learned societies, public institutions etc.).

MAIN TOPICS

◆ Horizon scanning – Horizon 2020, the new Strategic Research Agenda, IMI-2

◆ Science for the future – system pharmacology; precision medicines; pharmacogenetics/ pharmacogenomics; medicines safety; complex drug delivery; manufacturing and egulatory science

◆ Research consortia building

◆ Breakout sessions – e.g. on locally applied and locally acting drugs; future manufacturing and quality; nanosimilars; precision medicines; drug efficacy and safety – providing chances to meet, discuss and identify new opportunities